Edition:
United Kingdom

Rxi Pharmaceuticals Corp (RXII.OQ)

RXII.OQ on NASDAQ Stock Exchange Capital Market

2.77USD
20 Apr 2018
Change (% chg)

$0.01 (+0.54%)
Prev Close
$2.76
Open
$2.76
Day's High
$2.85
Day's Low
$2.76
Volume
30,343
Avg. Vol
43,602
52-wk High
$7.68
52-wk Low
$2.54

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.053
Jun '17 0.00 -1.123
Mar '17 0.00 -2.654
FY 2016 Dec '16 0.00 -6.015
Sep '16 0.00 -3.364
Jun '16 0.01 -3.385
Mar '16 0.01 -3.414
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta 1.75 0.90 0.88
Price to Sales (TTM) -- 110.89 5.71
Price to Book (MRQ) 2.00 13.58 5.37
Price to Tangible Book (MRQ) 2.00 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 2.69 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -100.00 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 66.83 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 10.13 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -41.62 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 3.30 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -- -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -9,925.65 -574.75 10.96
Operating Margin (TTM) -- -718.53 4.73
Operating Margin - 5 Yr. Avg. -10,000.32 -596.06 6.40
Pre-Tax Margin (TTM) -- -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -9,971.29 -599.42 6.81
Net Profit Margin (TTM) -- -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -9,971.29 -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,626,821 846,830,978
Net Income/Employee (TTM) -835,000 2,971,371 99,616,195
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -167.99 -1.11 10.95
Return on Assets - 5 Yr. Avg. -127.67 -0.57 12.31
Return on Investment (TTM) -229.71 1.58 14.38
Return on Investment - 5 Yr. Avg. -158.90 2.21 16.10
Return on Equity (TTM) -267.77 2.41 16.07
Return on Equity - 5 Yr. Avg. -855.83 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -44.12 -63.75 --
EPS (TTM) % 21.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rxi Pharmaceuticals Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.63 -6.95 55 53
13 Week -32.02 -35.33 19 65
26 Week -34.64 -39.61 35 77
52 Week -69.83 -74.43 14 50
YTD -28.67 -37.36 42 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.25%
# of Holders: 20
Total Shares Held: 1,202,071
3 Mo. Net Change: 1,146,823
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.